Publications & resources

Solid science. Validated knowledge.

Through collaborations with biopharma, investigators, and advocacy groups, ggomics is on a mission to transform how biomarker data are communicated to clinical stakeholders throughout the development cycle.

About the founder

Edik Blais, PhD

biomedical engineering — curriculum vitae

With over a decade of experience in real-world evidence and multi-omic analytics, Edik founded ggomics in the SF bay area to translate mechanistic modeling predictions into strategic insights.

Download CV Open CV Google Scholar ORCID Check his calendar & book a call Contact Page

Below is a curated selection from his 70+ publications.

Boost topic

Sort by year25 items

Lancet Oncology· 2020

PMID:32135080 PMCID:7453743 DOI:10.1016/S1470-2045(20)30074-7

Journal of Clinical Oncology (ASCO GI25 Conference)· 2025

DOI:10.1200/JCO.2025.43.4_suppl.776

Nature Communications· 2017

PMID:28176778 PMCID:5309818 DOI:10.1038/ncomms14250

JCO Precision Oncology· 2025

PMID:40834324 PMCID:12379785 DOI:10.1200/PO-24-00684

British Journal of Cancer· 2024

PMID:39322687 PMCID:11519601 DOI:10.1038/s41416-024-02852-y

JCO Precision Oncology· 2023

PMID:38085059 DOI:10.1200/PO.22.00648

British Journal of Cancer· 2019

PMID:31292535 PMCID:6738081 DOI:10.1038/s41416-019-0507-5

JCO Precision Oncology· 2021

PMID:34476331 PMCID:8407652 DOI:10.1200/PO.20.00494

JCO Precision Oncology· 2019

PMID:35100730 DOI:10.1200/PO.19.00115

Oncotarget· 2019

PMID:31692857 PMCID:6817448 DOI:10.18632/oncotarget.27265

JAMIA Open· 2019

PMID:32025647 PMCID:6994017 DOI:10.1093/jamiaopen/ooz045

The Oncologist· 2025

PMID:40079530 PMCID:11904785 DOI:10.1093/oncolo/oyaf007

Computers in Biology and Medicine· 2019

PMID:30584952 DOI:10.1016/j.compbiomed.2018.12.010

Journal of Clinical Investigation· 2020

PMID:32749238 PMCID:7456216 DOI:10.1172/JCI136760

Clinical Cancer Research· 2018

PMID:29954777 DOI:10.1158/1078-0432.CCR-18-0531

Journal of the National Comprehensive Cancer Network· 2021

PMID:33406492 PMCID:8765083 DOI:10.6004/jnccn.2020.7641

Journal of Biological Chemistry· 2010

PMID:20732875 PMCID:2962464 DOI:10.1074/jbc.M110.156075

Journal of Translational Medicine· 2024

PMID:38730319 PMCID:11087249 DOI:10.1186/s12967-024-05252-1

American Journal of Clinical Pathology· 2024

PMID:38642081 PMCID:11369068 DOI:10.1093/ajcp/aqae038

Toxicological Sciences· 2019

PMID:31501904 PMCID:6876259 DOI:10.1093/toxsci/kfz197

Surgical oncology· 2020

PMID:32561076 PMCID:7498307 DOI:10.1016/j.suronc.2020.02.003

PLoS ONE· 2014

PMID:25180633 PMCID:4152146 DOI:10.1371/journal.pone.0105631

PLoS ONE· 2013

PMID:24204737 PMCID:3799939 DOI:10.1371/journal.pone.0077065

PLoS ONE· 2012

PMID:22623999 PMCID:3356407 DOI:10.1371/journal.pone.0037231

Methods in Molecular Biology· 2013

PMID:23417799 PMCID:4079539 DOI:10.1007/978-1-62703-299-5_4

Want to talk about a specific publication?

Email info@ggomics.com or book a 30-minute scoping call.

Get in touch

Solid science. Validated knowledge.

Edik Blais, PhD

Overall survival in patients with pancreatic cancer receiving matched therapies following multi-omic molecular profiling

Validation of PDACai v2.0 in predicting relative benefit from frontline FOLFIRINOX (FFX) and gemcitabine/nab-paclitaxel (GA) for patients (pts) with metastatic pancreatic cancer (mPDAC)

Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions

Evaluating the Effect of KRAS Variants on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma

Functional activation of the AKT-mTOR signalling axis in a real-world metastatic breast cancer cohort

Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy

Multi-omic molecular comparison of primary versus metastatic pancreatic tumours

Retrospective Case Series Analysis of RAF Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard Therapies

Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results From the Know Your Tumor Program

Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations

A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patients

Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database

A simplified metabolic network reconstruction to promote understanding and development of flux balance analysis tools

Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix

Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative

Targeting the NTRK Fusion Gene in Pancreatic Acinar Cell Carcinoma: A Case Report and Review of the Literature

Testicular expression of Adora3i2 in Adora3 knockout mice reveals a role of mouse A3Ri2 and human A3Ri3 adenosine receptors in sperm

Keratin 17 modulates the immune topography of pancreatic cancer

Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma

Genome-Scale Characterization of Toxicity-Induced Metabolic Alterations in Primary Hepatocytes

A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution’s experience

A Thirteen-Gene Expression Signature Predicts Survival of Patients with Pancreatic Cancer and Identifies New Genes of Interest

Clinical, Molecular and Genetic Validation of a Murine Orthotopic Xenograft Model of Pancreatic Adenocarcinoma Using Fresh Human Specimens

Matrix Rigidity Regulates Cancer Cell Growth by Modulating Cellular Metabolism and Protein Synthesis

Linking genome-scale metabolic modeling and genome annotation

Want to talk about a specific publication?